PATENT CLAIM ANALYSIS

Application Number: 15745903
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "734000"]

Abstract:
Peritoneal therapeutic fluid comprising one or more of a biocompatibility enhancing agent (BCA) that is selected from the group consisting of a polyphenolic compound, a metabolite of a polyphenolic compound which is obtained by metabolization in the human or animal body, a salt or a glycoside of a polyphenolic compound.

Claim (Index 6):
A peritoneal therapeutic fluid according to  claim 1 , wherein the biocompatibility enhancing agent is selected from the group comprising:\n epsilon-viniferin, pallidol, trans-diptoindonesin B, hopeaphenol, oxyresveratrol, or 4\u2032-methoxy-(E)-resveratrol 3-O-rutinoside, phenolic acids such as gallic acid, ellagic acid, vanillic acid; propyl gallate, protocatechuic acid, p-coumaric acid, danielone, syringic acid, salicylic acid, gentisic acid, p-hydroxy benzoic acid, rosmarinic acid, rosmanol, quinic acid, sinapic acid, epi-isorosmanol, E-anethol, 3,4-dimethoxycinnamic acid, ferulic acid; phenolic diterpenes such as carnosol and carnosic acid; coumarines such as coumarin, ombelliferon, herniarine, esculedol, scopoletol, scopanone, fraxetol and their glucosides such as 7-O-glucosyl-ombelliferone, 6-O-glucosyl-esculetol, 7-O-glucosyl-esculetol, 7-O-Glucosyl-6-methoxycoumarine, dihydroxyisocoumarins such as 6-methoxymellein, as well as prenyloxycoumarines such as 7-geranyloxy coumarine, 7-methoxy-6-(3-methyl-2-butenyl)-coumarine, 7-methoxy-8-(3-methyl-2-butenyl)-coumarine; naphtoquinones such as 1,2-naphtoquinone, 1,4-Naphtoquinone, 2,6-Naphtoquinone, alkannin, hexahydroxy-1,4-naphthalenedione, juglone, lapachol, lawsone, menatetrenone, 2-methoxy-1,4-naphthoquinone, nigrosprin B, 2,3,5,7-tetrahydroxy-1,4-naphtalenedione, menadione, 5,8-Dihydroxy-1,4-naphtoquinone and other dihydroxynophtoquinones, atovaquone; flavonoids: anthoxanthins including flavonols such as quercetin, kaempferol, myricetin, fisetin, galangin, isorhamnetin, pachypodol, rhamnazin pyranoflavonols and furanoflavonols, flavones such as apigenin, and tangeritin, flavonoides including flavanones such as hesperetin and naringenin, eriodictoyl, homoeriodictoyl and sakuranetin, flavanonols such as taxifolin, dihydrolquercitin and dihydrokaempferol, flavans such as flavan-3ol (including Catechin, Gallocatechin, catechin 3\u2032-gallate, gallocatechin 3-gallate, epicatechin, epigallocatechin, epicatechin 3-gallate, Epigallocatechin 3-gallate, theaflavin, theaflavin-3-gallate, theaflavin-3,3\u2032-digallate, thearubigin, proaanthocyanidins, flavan-4-ol and flavan-3,4-diol; anthocyanins such as cyanidin, malvidin, pelargonidin, peonidin, petunidin, cyanin-3-rutinoside and delphinidin-3-rutinoside; isoflavonoides including isoflavones such as genistein, glycitein and daidzein, further including isoflavanes, isoflavenes, coumestans and pterocarpans stilbenoides including stilbene and aglycones such as piceatannol, pinosylvin, pterostilbene, or a mixture of two or more thereof.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.48649
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15523591', '11997765', '14084793', '13984991', '11554056']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7213919377355748
- 35 USC 102 Novelty (BERT): 0.4919351683404216
- Combined Prediction Score: 0.6984462607960594
- Mean Citation Score: 187.43985
- Max Citation Score: 194.85373
- Similarity Product: 131.13115541885674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test